Lung Magnetic Resonance Imaging with Diffusion Weighted Imaging Provides Regional Structural as well as Functional Information Without Radiation Exposure in Primary Antibody Deficiencies

Journal of Clinical Immunology

Volumn 35, Issue 5, 2015, Pages 491-500

  Milito, Cinzia ^a   Pulvirenti, Federica ^a   Serra, Goffredo ^b   Valente, Michele ^b   Pesce, Anna Maria ^a   Granata, Guido ^a   Catalano, Carlo ^b   Fraioli, Francesco ^c   Quinti, Isabella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

diffusion weighted imaging; GLILD; inflammation; lung abnormalities; magnetic resonance; Primary antibody deficiencies

Indexed keywords

CARBON MONOXIDE;

ADULT; ARTICLE; BHALLA SCORING SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; DIFFUSION WEIGHTED IMAGING; EMPHYSEMA; GRANULOMATOSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMORAL IMMUNE DEFICIENCY; INTERMETHOD COMPARISON; LUNG FUNCTION TEST; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIMARY ANTIBODY DEFICIENCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; ADVERSE EFFECTS; AGAMMAGLOBULINEMIA; COMMON VARIABLE IMMUNODEFICIENCY; COMPLICATION; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETIC DISEASES, X-LINKED; LUNG; MALE; MIDDLE AGED; PATHOLOGY; PREVENTION AND CONTROL; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIATION EXPOSURE; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGAMMAGLOBULINEMIA; COMMON VARIABLE IMMUNODEFICIENCY; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GENETIC DISEASES, X-LINKED; HUMANS; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIATION EXPOSURE; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937972629     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-015-0172-2     Document Type: Article

References (44)

1. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–48.
2. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308–16.
3. Quinti I, Soresina A, Guerra A, Rondelli R, Spadaro G, Agostini C, et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol. 2011;31:315–22.
4. Costa-Carvalho BT, Wandalsen GF, Pulici G, Aranda CS, Solé D. Pulmonary complications in patients with antibody deficiency. Allergol Immunopathol (Madrid). 2011;39:128–32.
5. Van de Ven AA, van Montfrans JM, Terheggen-Lagro SW, Beek FJ, Hoytema van Konijnenburg DP, Kessels OA, et al. A CT scan score for the assessment of lung disease in children with common variable immunodeficiency disorders. Chest. 2010;138:371–9.
6. Maarschalk-Ellerbroek LJ, de Jong PA, van Montfrans JM, Lammers JW, Bloem AC, Hoepelman AI, et al. CT screening for pulmonary pathology in common variable immunodeficiency disorders and the correlation with clinical and immunological parameters. J Clin Immunol. 2014;34:642–54.
7. Ballow M. Managing comorbid complications in patients with common variable immunodeficiency. Ann Allergy Asthma Immunol. 2013;111:S6–9.
8. Prasse A, Kayser G, Warnatz K. Common variable immunodeficiency-associated granulomatous and interstitial lung disease. Curr Opin Pulm Med. 2013;19:503–9.
9. Park JH, Levinson AI. Granulomatous-lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID). Clin Immunol. 2010;134:97–103.
10. Torigian DA, LaRosa DF, Levinson AI, Litzky LA, Miller Jr WT. Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings. J Thorac Imaging. 2008;23:162–9.
11. Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004;114:415–21.
12. Maglione PJ, Ko HM, Beasley MB, Strauchen JA, Cunningham-Rundles C. Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;133:535–42.
13. Da Silva SP, Resnick E, Lucas M, Lortan J, Patel S, Cunningham-Rundles C, et al. Lymphoid proliferations of indeterminate malignant potential arising in adults with common variable immunodeficiency disorders: unusual case studies and immunohistological review in the light of possible causative events. J Clin Immunol. 2011;31:784–91.
14. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119:1650–7.
15. Quinti I, Agostini C, Tabolli S, Brunetti G, Cinetto F, Pecoraro A, et al. Malignancies are the major cause of death in patients with adult onset common variable immunodeficiency. Blood. 2012;120:1953–4.
16. Offer SM, Pan-Hammarström Q, Hammarström L, Harris RS. Unique DNA repair gene variations and potential associations with the primary antibody deficiency syndromes IgAD and CVID. PLoS ONE. 2010;5:e12260.
17. Vorechovský I, Scott D, Haeney MR, Webster DA. Chromosomal radio sensitivity in common variable immune deficiency. Mutat Res. 1993;290:255–64.
18. Aghamohammadi A, Moin M, Kouhi A, Mohagheghi MA, Shirazi A, Rezaei N, et al. Chromosomal radiosensitivity in patients with common variable immunodeficiency. Immunobiology. 2008;213:447–54.
19. Palanduz S, Palanduz A, Yalcin I, Somer A, Ones U, Ustek D, et al. In vitro chromosomal radio sensitivity in common variable immune deficiency. Clin Immunol Immunopathol. 1998;86:180–2.
20. Serra G, Milito C, Mitrevski M, Granata G, Martini H, Pesce AM, et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest. 2011;140:1581–9.
21. Luna A, Sánchez-Gonzalez J, Caro P. Diffusion-weighted imaging of the chest. Magn Reson Imaging Clin N Am. 2011;19:69–94.
22. Nguyen TL, Soyer P, Barbe C, Graesslin O, Veron S, Amzallag-Bellenger E, et al. Diagnostic value of diffusion-weighted magnetic resonance imaging in pelvic abscesses. J Comput Assist Tomogr. 2013;37:971–9.
23. Ream JM, Dillman JR, Adler J, Khalatbari S, McHugh JB, Strouse PJ, et al. MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation. Pediatr Radiol. 2013;43:1077–85.
24. Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging. 2008;28:89–95.
25. Tondo F, Saponaro A, Stecco A, Lombardi M, Casadio C, Carriero A. Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum. Radiol Med. 2011;116:720–33.
26. Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S, Endo Y. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? AJR Am J Roentgenol. 2008;191:464–70.
27. Liu H, Liu Y, Tielian Y, Ye N. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol. 2010;20:807–15.
28. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies: representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93:190–7.
29. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991;179:783–8.
30. Padley SP, Adler B, Muller NL. High-resolution computed tomography of the chest: current indications. J Thorac Imaging. 1993;8:189–99.
31. Montella S, Mollica C, Finocchi A, Pession A, Pietrogrande MC, Trizzino A, et al. Non invasive assessment of lung disease in ataxia telangiectasia by high-field magnetic resonance imaging. J Clin Immunol. 2013;33:1185–91.
32. Lutterbey G, Grohé C, Gieseke J, von Falkenhausen M, Morakkabati N, Wattjes MP, et al. Initial experience with lung-MRI at 3.0 T: comparison with CT and clinical data in the evaluation of interstitial lung disease activity. Eur J Radiol. 2007;61:256–61.
33. Sheth VR, van Heeckeren RC, Wilson AG, van Heeckeren AM, Pagel MD. Monitoring infection and inflammation in murine models of cystic fibrosis with magnetic resonance imaging. J Magn Reson Imaging. 2008;28:527–32.
34. Klein M, Cohen-Cymberknoh M, Armoni S, Shoseyov D, Chisin R, Orevi M, et al. F-fluorodeoxyglucose-PET/CT imaging of lungs in patients with cystic fibrosis. Chest. 2009;136:1220–8.
35. Amin R, Charron M, Grinblat L, Shammas A, Grasemann H, Graniel K, et al. Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT. Radiology. 2012;264:868–75.
36. Uto T, Takehara Y, Nakamura Y, Naito T, Hashimoto D, Inui N, et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology. 2009;252:247–54.
37. Kuruvilla M, de la Morena MT. Antibiotic prophylaxis in primary immune deficiency disorders. J Allergy Clin Immunol Pract. 2013;1:573–82.
38. Burtin C, Hebestreit H. Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: Exercise and physical activity interventions in cystic fibrosis and non-cystic Fibrosis Bronchiectasis. Respiration, 2015 Feb 12.
39. Rakhmanov M, Gutenberger S, Keller B, Schlesier M, Peter HH, Warnatz K. CD21low B cells in common variable immunodeficiency do not show defects in receptor editing, but resemble tissue-like memory B cells. Blood. 2010;116:3682–3.
40. Park J, Munagala I, Xu H, Blankenship D, Maffucci P, Chaussabel D, et al. Interferon signature in the blood in inflammatory common variable immune deficiency. PLoS ONE. 2013;8:e74893.
41. Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency - an update. Arthritis Res Ther. 2012;14:223.
42. Chase NM, Verbsky JW, Hintermeyer MK, Waukau JK, Tomita-Mitchell A, Casper JT, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). 2013,33:30–9.
43. Franxman TJ, Howe LE, Baker JR Jr J. Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency. Clin Immunol. 2014;34:820–7.
44. Cunningham-Rundles C. Lung disease, antibodies and other unresolved issues in immune globulin therapy for antibody deficiency. Clin Exp Immunol. 2009;157:12–6.